Formaderm (Hyaluronic Acid) for Facial Soft Tissue Augmentation

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to evaluate the safety and efficacy of Formaderm (hyaluronic acid) dermal filler injection for soft tissue augmentation. The main questions it aims to answer are: - The differences of Wrinkle Severity Rating Scale (WSRS) after the injection. - The differences of Global Aesthetic Improvement Scale (GAIS) after the injection. - The subjective satisfaction of treatment. - Safety Indicators of which incidences on the day of the injection or after the injection. Participants will be self-controlled and randomized for same period - received both trial product and control product at the same time. - re-visited on week 2, 4, 12, 24, 36, and 52 after injection. Researchers will compare if the test product is non-inferiority to Q-Med Restylane.

Clinical Trial Description

The purpose of this study is to evaluate the safety and efficacy of Formaderm (hyaluronic acid) dermal filler injection for soft tissue augmentation. A single-centre, non-inferior, randomized, double-blind trial with a control group was conducted in this study. Every subject received the trial product and control product injections at the same time. It was planned to recruit 95 subjects with the 10% dropout rate. This clinical trial is accordance with the "Good Clinical Practice (GCP) issued by the Department of Health and ISO14155-1：2003 Clinical investigation of medical devices for human subjects - Part 1: General Requirements and carried out according to the trial proposal approved by the Tri-Service General Hospital Human Subjects Review Committee. ;

Study Design

Related Conditions & MeSH terms

Dermal Filler

Clinical Trial Details

NCT number	NCT05822778
Study type	Interventional
Source	Maxigen Biotech Inc.
Contact
Status	Completed
Phase	N/A
Start date	February 13, 2014
Completion date	June 30, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04546516` - Safety and Efficacy of the HA-based Dermal Fillers HYAcorp Lips and Face
Completed	`NCT04546152` - Safety and Efficacy of the HA-based Dermal Fillers HYAPROF® SOFT and HYAPROF® BALANCE
Active, not recruiting	`NCT05694286` - A Prospective Evaluation of Infraorbital Filler Injection	N/A
Completed	`NCT02654522` - The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers	Phase 1
Completed	`NCT05294562` - China Post-Market Clinical Follow-up of FACILLE®
Completed	`NCT04569045` - Evaluate the Safety and Effectiveness of Sodium Hyaluronate When Used for the Correction of Nasolabial Folds	N/A
Completed	`NCT04622085` - The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face	N/A
Completed	`NCT04599335` - The Evaluation of the Safety and Effectiveness of a Novel Gel-type Sodium Hyaluronate for the Correction of Aging Mid-face	N/A
Recruiting	`NCT05853224` - An Interventional Study to Evaluate the Safety and Performance of Crosslinked Hyaluronic Acid Hydrogel	N/A